Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study

被引：0
|
作者：
Meghan E. Jones
Jeffrey S. Andrews
Douglas E. Faries
John Landry
Jenny Xu
Holland C. Detke
Rashna Chhabra-Khanna
David P. McDonnell
机构：
[1] Eli Lilly and Company,
[2] Eli Lilly Canada,undefined
[3] Inc.,undefined
[4] MacroStat (China) Clinical Research Co.,undefined
[5] Ltd.,undefined
[6] Lilly UK,undefined
[7] Eli Lilly and Company,undefined
来源：
BMC Psychiatry | / 15卷
关键词：
Olanzapine; Long-acting injection; Schizophrenia; Antipsychotics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Characteristics of Chinese patients with advanced prostate cancer: A muliticentre, non-interventional, observational, prospective, registry study of docetaxel.
    He, Dalin
    Sun, Zhongquan
    Guo, Jianming
    Zhang, Zhigen
    Shan, Yuxi
    Ma, Lulin
    Li, Hanzhong
    Jin, Jie
    Huang, Yiran
    Xiao, Jiaquan
    Wei, Qiang
    Ye, Dingwei
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [32] EFFICACY AND SAFETY OF OLANZAPINE LONG-ACTING INJECTION IN PATIENTS WITH SCHIZOPHRENIA: A POST-HOC ANALYSIS OF A 6-YEAR, MULTINATIONAL, SINGLE-ARM, OPEN-LABEL STUDY
    Anand, Ernie
    Berggren, Lovisa
    Toth, Agoston
    McDonnell, David
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S291 - S291
  • [33] The Effectiveness of Risperidone Long-acting Injection in Oral Antipsychotic Non-Adherent Patients with Schizophrenia: A Retrospective Study
    Akkaya, Cengiz
    Sarandol, Asli
    Kotan, Vahap Ozan
    Cangur, Sengul
    Aydin, Ayseguel
    Kirli, Selcuk
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 19 (03): : 255 - 262
  • [34] Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data
    Holland C Detke
    Fangyi Zhao
    Michael M Witte
    BMC Psychiatry, 12
  • [35] BASELINE DEMOGRAPHICS AND CLINICAL CHARACTERISTICS FROM A PROSPECTIVE, RANDOMIZED, OPEN-LABEL STUDY OF PALIPERIDONE PALMITATE LONG-ACTING INJECTION IN SUBJECTS WITH RECENT-ONSET SCHIZOPHRENIA OR SCHIZOPHRENIFORM DISORDER
    Brown, Brianne
    Turkoz, Ibrahim
    Yue, Yong
    Alphs, Larry
    SCHIZOPHRENIA BULLETIN, 2017, 43 : S117 - S117
  • [36] Interim results of the phase IV JAKoMo trial, a prospective, non-interventional study of symptoms and quality of life in myelofibrosis patients receiving ruxolitinib therapy
    Wehrle, J.
    Geer, T.
    Brudler, O.
    Schaefer, E.
    Tesch, H.
    Cavanna, D.
    Bachhuber, P.
    Markhauser, M.
    Koschmieder, S.
    Mesa, R. A.
    Pahl, H. L.
    Oncology Research and Treatment, 2015, 38 : 227 - 228
  • [37] Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data
    Detke, Holland C.
    Zhao, Fangyi
    Witte, Michael M.
    BMC PSYCHIATRY, 2012, 12
  • [38] CLINICAL CHARACTERISTICS AND OUTCOMES OF 'EARLY SWITCHERS': A SUBSET OF PATIENTS FROM XALIA, A PROSPECTIVE NON-INTERVENTIONAL STUDY
    Turpie, Alexander G. G.
    Mantovani, Lorenzo G.
    Haas, Sylvia
    Kreutz, Reinhold
    Monje, Danja
    Schneider, Jonas
    van Eickels, Martin
    Gebel, Martin
    Ageno, Walter
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (09) : E430 - E430
  • [39] Single- and Multiple-Dose Pharmacokinetic, Safety, and Tolerability Profiles of Olanzapine Long-Acting Injection: An Open-Label, Multicenter, Nonrandomized Study in Patients With Schizophrenia
    Mitchell, Malcolm
    Kothare, Prajakti
    Bergstrom, Richard
    Zhao, Fangyi
    Jen, Kai Yu
    Walker, Daniel
    Johnson, Jason
    McDonnell, David
    CLINICAL THERAPEUTICS, 2013, 35 (12) : 1890 - 1908
  • [40] Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia
    Karagianis, J.
    Guilliver, A.
    Sun, B.
    Zhao, F.
    Watson, S.
    McDonnell, D.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 223 - 223
12345